Consensus Chengdu Olymvax Biopharmaceuticals Inc.

Equities

688319

CNE1000051H8

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
8.51 ^CNY	-2.30%		-1.16%	-46.14%

05-16	Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials	MT
04-25	Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Chengdu Olymvax Biopharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

dc9d7312806d96074d06973f.N5reP6yLGTDPkqpaK7eQRNAvPiwKqSYtYtNmyT6k3I4.dfOBXJvufB2h9P9tHdviDZh_Exg73h96C-slqlvGhupG9ZtG78RjB53d3Q~69a21d9b640c8641841848bc838673f4